Next, we measure the levels of STAT3 phosphorylation in tumor samples and found that the in vivo treatment of luteolin significantly downregulated STAT3 phosphorylation and Mcl-1, Bcl-xl, Survivin expression at both protein and transcription levels (Figures 5e and g). This evidence concerns the gene BIRC5 and neoplasm.